As a Partner at Echo Health Ventures in Boston, Jessica A. Zeaske, PhD, identifies and invests in emerging and growth stage companies for Echo. She is a seasoned venture capitalist and board leader having worked at independent, corporate, and university funds and written dozens of investment themes over the years. She previously served as Director of Healthcare Investments at GE Ventures where she invested in precision health companies. Jessica came to GE Ventures from Lemhi Ventures, a fund investing in health care services with a focus on market disruption. Prior to joining Lemhi, Jessica worked on forming and spinning out MedTech and Life Science companies based on University intellectual property at U of Minnesota and Oregon Health & Science University. Jessica began her career writing software for a start-up health care delivery company. She then moved to a merchant bank, Greenspring Advisors, where they launched and invested in data-driven health care start-up companies.

Jessica received an undergraduate degree with honors from Stanford University, graduated from Johns Hopkins School of Public Health with a Master of Health Science and PhD, and completed her MBA with a focus on Healthcare Administration at Regis University. Jessica currently serves on the Boards of Genome Medical and Wildflower Health and is a Board Observer at Abacus Insights. Her previous Board of Director experience includes Apervita,, PlanSource, OneHealth, PokitDok, Orasi Medical, Medication Management Solutions and multiple Observer seats. Jessica coaches early stage companies in the public health sector, serves as a start-up judge and panelist for multiple health care conferences, and mentors individuals via the CSweetener and B7 programs. Jessica serves as a Trustee for the Exceptional Care Without Exception Trust for Boston Medical Center and is an Advisory Board member for Boston Children’s Hospital.